Valuation: Certara, Inc.

Market Cap 1.08B 946M 875M 804M 1.52B 104B 1.54B 10.46B 4.1B 50.94B 4.05B 3.97B 176B P/E 2026 *
-69.4x
P/E 2027 * -694x
Enterprise Value 1.15B 1.01B 935M 860M 1.62B 111B 1.65B 11.18B 4.38B 54.47B 4.33B 4.24B 188B EV / Sales 2026 *
2.9x
EV / Sales 2027 * 2.62x
Free-Float
69.31%
Yield 2026 *
-
Yield 2027 * -
1 day+0.14%
1 week+2.21%
Current month+5.95%
1 month+25.27%
3 months+12.12%
6 months-26.87%
Current year-21.23%
1 week 6.74
Extreme 6.74
7.4
1 month 5.3
Extreme 5.305
7.4
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.88
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2026
Director of Finance/CFO 53 15/07/2026
President 62 01/08/2023
Director TitleAgeSince
Chairman 72 01/12/2021
Director/Board Member 68 01/01/2013
Director/Board Member 59 01/08/2017
Date Insider Type Main position Quantity % Market Cap.
7/15/26 A Other

Chief Financial Officer

191,850 0.1233%
6/1/26 A Fiscal year

General Counsel

57,763 0.0371%
6/1/26 A Fiscal year

Head of Human Resources

16,535 0.0106%
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%+2.21%-31.29%-63.53% 1.08B
+2.15%+2.89%-21.13%+15.98% 2,925B
+1.87%+3.70%-12.16%+687.22% 317B
+1.55%-13.02%+209.19%+923.53% 110B
+1.74%+1.14%+81.49%+139.49% 92.08B
-0.05%-12.70%+4.55%+38.17% 91.05B
-1.51%-12.76%-35.28%-16.22% 73.58B
+1.58%-4.49%-37.29%+75.68% 63.73B
+0.97%-2.10%+3.37%+57.60% 43.94B
+3.04%-3.23%-57.23%+29.75% 37B
Average +1.15%-4.61%+10.42%+188.77% 375.56B
Weighted average by Cap. +1.96%+0.96%-11.09%+103.91%

Financials

2026 *2027 *
Net sales 399M 349M 323M 297M 560M 38.44B 569M 3.86B 1.51B 18.81B 1.5B 1.46B 64.8B 405M 355M 329M 302M 570M 39.1B 579M 3.93B 1.54B 19.13B 1.52B 1.49B 65.91B
Net income -16.86M -14.78M -13.66M -12.56M -23.7M -1.63B -24.08M -163M -64.02M -795M -63.3M -61.92M -2.74B -2.39M -2.09M -1.93M -1.78M -3.36M -230M -3.41M -23.13M -9.07M -113M -8.97M -8.77M -388M
Net Debt 74.77M 65.54M 60.58M 55.71M 105M 7.21B 107M 724M 284M 3.53B 281M 275M 12.15B -17.2M -15.07M -13.93M -12.81M -24.18M -1.66B -24.57M -167M -65.31M -811M -64.58M -63.17M -2.8B
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions, providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,600 biopharmaceutical companies, academic institutions and biotech companies across 70 countries.
Employees
1,546
Date Price Change Volume
20/07/26 $6.940 +0.14% 1,942,078
17/07/26 $6.930 -4.81% 2,140,868
16/07/26 $7.280 +3.12% 4,635,968
15/07/26 $7.060 +5.85% 2,593,526
14/07/26 $6.670 -1.77% 2,220,047
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
6.940USD
Average target price
7.530USD
Spread / Average Target
+8.50%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CERT Stock